🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

health is both the most valuable commodity & a Jevons good. the more healthy years/$ you can buy, the more total health spending will *increase*. there's no upper bound on value for therapeutic & enhancement products that really work.

New Limit has just raised $130 million from the likes of Patrick Collison Nat Friedman Joshua Kushner and others. And we have a podcast to prove it corememory.com/p/the-company-…

.NewLimit is building medicines that target aging itself—not just individual diseases. Their approach is elegant and deeply technical: run the largest epigenetic reprogramming experiments and use the data to train frontier AI models. Proud to lead their Series B and back

NEW: Brian Armstrong’s NewLimit raises a $130M Series B, laying out road map for anti-aging drugs I talked with Jacob Kimmel on NewLimit's progress & what comes next: endpts.com/anti-aging-bio…

we're entering a new phase NewLimit & beginning to progress our first medicines for aging & disease. now more than ever, we're confident that reprogramming biology will unlock more healthy years in each life. it's a privilege to build this future with generational partners.

Thrilled to announce that we are doubling down and leading the Series B of NewLimit!   Brian Armstrong, Blake Byers, Jacob Kimmel, Cathy O’Hare and the NewLimit team are on a radical mission to extend healthspan by leveraging epigenetic reprogramming, AI and scaled genomics to

Honored to back the incredible NewLimit team with Nat Friedman and Daniel Gross Excited to partner with good friends and visionary founders Blake Byers Brian Armstrong Jacob Kimmel on this intrepid mission to reprogram biology for healthspan and disease 🧬

We’ve raised a $130 million Series B led by Kleiner Perkins alongside new investors Nat Friedman/Daniel Gross , Vinod Khosla, and HUMAN CAPITAL — joined by existing investors Founders Fund , DIMENSION, and Brian Armstrong (yes, the cofounders are doubling down). We also raised

Leading NewLimit's Series A was amongst the first investments we made at DIMENSION. Today is pivotal, bringing in new proceeds & iconic world class investors, as we continue the march to slow & reverse aging. Congrats to Jacob Kimmel Blake Byers & Brian Armstrong!

Congrats to my brother Blake Byers and friends Brian Armstrong and Jacob Kimmel on the raise. Long way to go, but radically extending human healthspan is a mission worthy of significant time and resources.

excited to chat with technology brothers John Coogan & Jordi Hays this afternoon

Congrats to the entire team at @NewLimit, led by Jacob Kimmel, Cathy O'Hare, and Blake Byers who deserve the credit for making this milestone possible! Exciting progress, and lots to build.

BREAKING: Jacob Kimmel on closing $130M in funding for NewLimit and how epigenetic marks work "All the cells in your body have the same DNA code. Since they have the same code base, it presents a question: how do your eyeball, kidney and tongue all do different things?" "The

5.7.25 – Jacob Kimmel on today to talk about NewLimit’s $130M Series B and: • How mRNA & reprogramming factors could reverse aging in the liver • Why the immune system may be the most high-leverage path to longer healthspans • How AI unlocked a search space of 10¹⁶ possible

the best days are ahead NewLimit

Excited to share that we've invested in NewLimit's $130M Series B - founded by CEO of Coinbase 🛡️, Brian Armstrong - alongside Kleiner Perkins, Khosla, Founders Fund, Nat Friedman, Daniel Gross, Elad Gil, Garry Tan, Patrick Collison, and more. At Draper Associates, we believe longevity

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: NewLimit raised a $130M series B round last week to advance its work using epigenetic reprogramming to improve cell function and thus aim to extend longevity. Full video: biotechtv.com/post/newlimit-…

Our podcast with Jacob Kimmel on New Limit's efforts to try and reverse aging in our organs youtube.com/watch?v=QT4CuN…

we generated the most visually striking data of my career NewLimit this week we have a real opportunity to create medicines that add healthy years for everyone. come join us if you’re excited to pull that future into the present.

Atul was an inspiration to a generation of scientists at the intersection of computer science & biomedicine the lessons he conferred will live on for many years to come